AstraZeneca PLC
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceutical therapy. It essentially delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule. RBC Capital Markets sees a $25 […]
Read More
A corner of the cancer therapy market is heating up—Here are the names investors need to know
There’s been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor. There are currently two products on the market from Novartis and a slew of clinical […]
Read More
Stocks producing the greatest moves midday: Peloton, Lam Investigation, Lowe’s, AstraZeneca and extra
Test out the businesses making the greatest moves midday: Peloton — The stock plunged 14% subsequent the linked fitness firm’s announcement it will commence a “world wide refinancing” process that contains a convertible notes offering and a $1 billion five-calendar year expression loan. Peloton, which just lately declared a restructuring system , has struggled with […]
Read More
European markets lower as positive momentum fades
AstraZeneca is in its ‘post-Covid era’, CFO says AstraZeneca shares were 0.6% higher at 9:45 a.m. in London, after the company said it plans to increase its total revenue to $80 billion by 2030, up 75% from $45.8 billion in 2023. It will focus on its oncology, biopharmaceuticals and rare diseases businesses and expects to […]
Read More
AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’
The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty Images LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. “We have […]
Read More
Pfizer and AstraZeneca announce new investments of practically $1 billion in France
Sopa Images | Lightrocket | Getty Photographs Major healthcare corporations Pfizer and AstraZeneca announced on Sunday new investments in France worthy of a whole of virtually $1 billion, ahead of the get started of this year’s yearly ‘Choose France’ small business summit. Pfizer reported it would devote 500 million euros ($538.5 million) in France to develop up […]
Read More
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
In this photo illustration a covid-19 vaccine is seen with the AstraZeneca logo in the background. (Photo Illustration by Nikos Pekiaridis/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined. The so-called Vaxzevria vaccine was developed […]
Read More
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly’s weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois. Scott Olson | Getty Images Novo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but their duopoly is closer than ever to facing a threat from a new rival. Amgen […]
Read More
FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs, including Novo Nordisk’s blockbuster drugs Ozempic, Saxenda and Victoza. The […]
Read More
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drugmakers spent big on advertisements for weight loss and diabetes treatments last year […]
Read More